Cargando…
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040539/ https://www.ncbi.nlm.nih.gov/pubmed/33844998 http://dx.doi.org/10.1016/S2213-2600(21)00171-5 |
| _version_ | 1783677803149918208 |
|---|---|
| author | Agusti, Alvar Torres, Ferran Faner, Rosa |
| author_facet | Agusti, Alvar Torres, Ferran Faner, Rosa |
| author_sort | Agusti, Alvar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8040539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80405392021-04-13 Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 Agusti, Alvar Torres, Ferran Faner, Rosa Lancet Respir Med Comment Elsevier Ltd. 2021-07 2021-04-09 /pmc/articles/PMC8040539/ /pubmed/33844998 http://dx.doi.org/10.1016/S2213-2600(21)00171-5 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Agusti, Alvar Torres, Ferran Faner, Rosa Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title | Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title_full | Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title_fullStr | Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title_full_unstemmed | Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title_short | Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 |
| title_sort | early treatment with inhaled budesonide to prevent clinical deterioration in patients with covid-19 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040539/ https://www.ncbi.nlm.nih.gov/pubmed/33844998 http://dx.doi.org/10.1016/S2213-2600(21)00171-5 |
| work_keys_str_mv | AT agustialvar earlytreatmentwithinhaledbudesonidetopreventclinicaldeteriorationinpatientswithcovid19 AT torresferran earlytreatmentwithinhaledbudesonidetopreventclinicaldeteriorationinpatientswithcovid19 AT fanerrosa earlytreatmentwithinhaledbudesonidetopreventclinicaldeteriorationinpatientswithcovid19 |